Source: International Congress 2019 – Novel targets and mechanisms in asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Huang (Cardiff, United Kingdom), B. Mansfield (Cardiff, United Kingdom), X. Du (Beijing, China), Q. Huang (Beijing, China), W. Wang (Beijing, China), F. William (Cardiff, United Kingdom), E. Kidd (Cardiff, United Kingdom), C. Corrigan (London, United Kingdom), J. Ward (London, United Kingdom), P. Kemp (Cardiff, United Kingdom), Y. Sun (Beijing, China), D. Riccardi (Cardiff, United Kingdom). Therapeutic effects of topical calcilytic in IgE/Th2 and alarmin-driven surrogates of human asthma. 4958

Member's Comments

No comment yet.

Related content which might interest you: Comparable efficacy of calcilytic and corticosteroid in short-term and long-term allergic asthma models in vivo Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma? Source: Eur Respir J 2001; 17: 1059-1061 Year: 2001 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005 How effective are oral steroids in asthma action plans? Source: International Congress 2017 – Asthma management Year: 2017 Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018 Year: 2019 Pharmacological characterization of CHF6162, a novel long acting inhaled corticosteroid for the treatment of asthma Source: International Congress 2017 – Novel mechanisms and treatments for asthma Year: 2017 Tralokinumab did not demonstrate oral corticosteroid-sparing effects in severe asthma Source: Eur Respir J, 53 (2) 1800948; 10.1183/13993003.00948-2018 Year: 2019 Combining corticosteroids and NK1R antagonists: A new drugs combination to treat allergic diseases Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Prolonged activity where it matters - the reversible esterfication of budesonide improves its topical anti-inflammatory efficacy and selectivity in the airways Source: Eur Respir J 2001; 18: Suppl. 33, 21s Year: 2001 Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Source: Eur Respir J 2004; 24: 1-2 Year: 2004 The effects of addition montelukast to inhaled steroids in the regular treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 262s Year: 2001 Advantageous toxicity profile of an inhaled GATA-3-specific DNAzyme intended for anti-inflammatory treatment of Th2-driven asthma Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD Year: 2012 Efficacy and safety of BI 671800, an oral CRTH2 antagonist, as add on therapy in poorly controlled asthma patients prescribed an inhaled corticosteroid Source: Annual Congress 2012 - Trials in asthma: asthma exacerbations and severe asthma Year: 2012 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Clinical evolution of potroom asthma - effects of introducing montelukast to standard treatment with corticosteroid and beta-agonists Source: Eur Respir J 2001; 18: Suppl. 33, 278s Year: 2001 Preclinical in vivo assessment of ciclesonide, a novel corticosteroid for the treatment of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Low-dose inhaled glucocorticoids are more effective tham LTRA in improving functional data in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 126s Year: 2004